Mobilization of hematopoietic stem cells in a thalassemic mouse model: Implications for human gene therapy of thalassemia

Human Gene Therapy

Volumn 21, Issue 3, 2010, Pages 299-310

  Yannaki, Evangelia ^a   Psatha, Nikoleta ^a,b   Athanasiou, Evangelia ^a   Karponi, Garyfalia ^a   Constantinou, Varnavas ^a   Papadopoulou, Anastasia ^a,b   Tasouli, Athanasia ^a,b   Kaloyannidis, Panayotis ^a   Batsis, Ioannis ^a   Arsenakis, Minas ^b   Anagnostopoulos, Achilles ^a   Fassas, Athanasios ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GENE THERAPY; HEMATOPOIETIC STEM CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SPLEEN HEMATOMA; SPLEEN INFARCTION; SPLEEN RUPTURE; SPLENECTOMY; STEM CELL MOBILIZATION; THALASSEMIA;

ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE THERAPY; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEMOGLOBINS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; SPLENECTOMY; THALASSEMIA;

ANIMALIA; MUS;

EID: 77949733300     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.077     Document Type: Article

References (56)

1. Abboud, M., Laver, J., and Blau, C.A. (1998). Granulocytosis causing sickle-cell crisis. Lancet 351, 959.
2. Adler, B., Salzman, D., Carabasi, M., Vaughan, W.P., Reddy, V.V., and Prchal, J.T. (2001). Fatal sickle cell crisis after gran-ulocyte colony-stimulating factor administration. Blood 97, 3313-3314.
3. An, D.S., Kung, S.K., Bonifacino, A., Wersto, R.P., Metzger, M.E., Agricola, B.A., Mao, S.H., Chen, I.S., and Donahue, R.E. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common g-chain cytokine receptor in rhesus macaques. J. Virol. 75, 3547-3555.
4. Balaguer, H., Galmes, A., Ventayol, G., Bargay, J., and Be-salduch, J. (2004). Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor. Transfusion 44, 1260-1261.
5. Bank, A., Dorazio, R., and Leboulch, P. (2005). A phase I=II clinical trial of b-globin gene therapy for b-thalassemia. Ann. N.Y. Acad. Sci. 1054, 308-316.
6. Becker, P.S., Wagle, M., Matous, S., Swanson, R.S., Pihan, G., Lowry, P.A., Stewart, F.M., and Heard, S.O. (1997). Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in allogeneic donor of peripheral blood stem cells. Biol. Blood Marrow Transplant. 3, 45-49.
7. Beyer, J., Schwella, N., Zingsem, J., Strohscheer, I., Schwaner, I., Oettle, H., Serke, S., Huhn D., and Stieger, W. (1995). Hema-topoietic rescue after high-dose chemotherapy using autolo-gous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J. Clin. Oncol. 13, 1328-1335.
8. Bodine, D., Seidel, N., and Orlic, D. (1996). Bone marrow collected 14 days after in vivo administration of Granulocyte Colony-Stimulating factor and Stem Cell factor to mice has 10fold more repopulating ability than untreated bone marrow. Blood 88, 89-97.
9. Brown, S.L., and Dale, D.C. (1997). Spontaneous rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells, Biol. Blood Marrow Transplant. 3, 341-343.
10. \+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and=or cytokine treatment: Compassionate use data. Bone Marrow Transplant. 41, 331-338.
11. Cottler-Fox, M.H., Lapidot, T., Petit, I., Kollet, O., DiPersio, J.F., Link, D., and Devine, S. (2003). Stem cell mobilization. He-matology Am. Soc. Hematol. Educ. Program 2003, 419-437.
12. Cronkite, E.P., Burlington, H., Shimosaka, A., Bullis, J.E., and Pappas, N. (1993). Anemia induced in splenectomized mice by administration of rhG-CSF. Exp. Hematol. 21, 319-325.
13. de Haan, G., Loeffler, M., and Nijhof, W. (1992). Long-term re-combinant human granulocyte factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia. Exp. Hematol. 20, 600.
14. \+ cells following administration of the CXCR4 antagonist AMD3100topatients with multiple myeloma and non-Hodgkin's lymphoma. J. Clin. Oncol. 22, 1095-1102.
15. Dunbar, C.E., Seidel, N.E., Doren, S., Sellers, S., Cline, A.P., Metzger, M.E., Agricola, B.A., Donahue, R.E., and Bodine, D.M. (1996). Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 93, 11871-11876.
16. Eldor, A., and Rachmilewitz, E.A. (2002). The hypercoagulable state in thalassemia. Blood 99, 36-43.
17. Eldor, A., Durst, R., Hy-Am, E., Goldfarb, A., Gillis, S., Rach-milewitz, E.A., Abramov, A., MacLouf, J., Godefray, Y.C., De Raucourt, E., and Guillin, M.C. (1999). A chronic hypercoag-ulable state in patients with b-thalassemia major is already present in childhood. Br. J. Haematol. 107, 739-746.
18. Falzetti, F., Aversa, F., Minelli, O., and Tabilio, A. (1999). Spontaneous rupture of spleen during peripheral blood stem cell mobilisation in a healthy donor. Lancet 353, 555.
19. Flomenberg, N., Devine, S.M., Dipersio, J.F., Liesveld, J.L., McCarty, J.M., Rowley, S.D., Vesole, D.H., Badel, K., and Calandra, G. (2005). The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106, 1867-1874.
20. Fukumoto, Y., Miyamoto, T., Okamura, T., Gondo, H., Iwasaki, H., Horiuchi, T., Yoshizawa, S., Inaba, S., Harada, M., and Niho, Y. (1997). Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br. J. Haematol. 97, 666-668.
21. Gaia, S., Smedile, A., Omedè, P., Olivero, A., Sanavio, F., Bal-zola, F., Ottobrelli, A., Abate, M.L., Marzano, A., Rizzetto, M., and Tarella, C. (2006). Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver cirrhosis. J. Hepatol. 45, 13-19.
22. Geiger, H., Szilvassy, S.J., Ragland, P., and Van Zant, G. (2004). Genetic analysis of progenitor cell mobilization by granulocyte colony-stimulating factor: Verification and mechanisms for loci on murine chromosomes 2 and 11. Exp. Hematol. 32, 60-67.
23. \+ thalassemia. Blood 97, 3998-3999.
24. Hartmann, O., Le Corroller, A.G., Blaise, D., Michon, J., Philip, I., Norol, F., Janvier, M., Pico, J.L., Baranzelli, M.C., Rubie, H., Coze, C., Pinna, A., Méresse, V., and Benhamou, E. (1997). Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. A randomized controlled trial. Ann. Intern. Med. 126, 600-607.
25. Horn, P.A., Keyser, K.A., Peterson, L.J., Neff, T., Thomasson, B.M., Thompson, J., and Kiem, H.P. (2004). Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 103, 3710-3716.
26. Imren, S., Payen, E., Westerman, K.A., Pawliuk, R., Fabry, M.E., Eaves, C.J., Cavilla, B., Wadsworth, L.D., Beuzard, Y., Bou-hassira, E.E., Russell, R., London, I.M., Nagel, R.L., Leboulch, P., and Humphries, R.K. (2002). Permanent and panerythroid correction of murine b thalassemia by multiple lentiviral integration in hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99, 14380-14385.
27. Kojima, S., Fukuda, M., Miyajima, Y., Matsuyama, T., and Horibe, K. (1991). Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 77, 937-941.
28. Li, K., Wong, A., Li, C.K., Shing, M.M., Chik, K.W., Tsang, K.S., Lai, H., Leung, T.F., and Yuen, P.M. (1999). Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in b-thalassemia patients: Kinetics of mobilization and composition of apheresis product. Exp. Hematol. 27, 526-532.
29. Liles, W.C., Broxmeyer, H.E., Rodger, E., Wood, B., Hü bel, K., Cooper, S., Hangoc, G., Bridger, G.J., Henson, G.W., Calandra, G., and Dale, D.C. (2003). Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102, 2728-2730.
30. \+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 45, 295-300.
31. Lindemann, A., and Rumberger, B. (1993). Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur. J. Cancer 29A, 2338-2339.
32. May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K.M., Luzzatto, L., and Sadelain, M. (2000). Therapeutic haemoglobin synthesis in b-thalassaemic mice expressing lentivirus-encoded human b-globin. Nature 406, 82-86.
33. Miccio, A., Cesari, R., Lotti, F., Rossi, C., Sanvito, F., Ponzoni, M., Routledge, S.J., Chow, C.M., Antoniou, M.N., and Ferrari, G. (2008). In vivo selection of genetically modified erythroblas-tic progenitors leads to long-term correction of b-thalassemia. Proc. Natl. Acad. Sci. U.S.A. 10547-10552.
34. Miles, S.A., Mitsuyasu, R.T., Lee, K., Moreno, J., Alton, K., Egrie, J.C., Souza, L., and Glaspy, J.A. (1990). Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection. Blood 75, 2137-2142.
35. Molineux, G., Pojda, Z., and Dexter, T.M. (1990). A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 75, 563-569.
36. O'Malley, D.P., Whalen, M., and Banks, P.M. (2003). Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome. Am. J. Hema-tol. 73, 294-295.
37. Papaldo, P., Ferretti, G., Di Cosimo, S., Giannarelli, D., Marolla, P., Lopez, M., Cortesi, E., Antimi, M., Terzoli, E., Carlini, P., Vici, P., Botti, C., Di Lauro, L., Naso, G., Nisticò, C., Mottolese, M., Di Filippo, F., Ruggeri, E.M., Ceribelli, A., and Cognetti, F. (2006). Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide? J. Clin. Oncol. 19, 3048-3054.
38. Papayannopoulou, T. (2004) Current mechanistic scenarios in hematopoietic stem=progenitor cell mobilization. Blood 103, 1580-1585.
39. Papayannopoulou, T., and Scadden, D. (2008). Stem-cell ecology and stem cells in motion. Blood 111, 3923-3930.
40. Park, K., Im, T., Sasaki, A., Yamane, T., Nakao, Y., Yasui, Y., Ota, K., Ohira, H., Inoue, T., and Furukawa, Y. (1991). Positive effects of granulocyte colony-stimulating factor on erythro-poiesis in humans. Osaka City Med. J. 2, 123-132
41. Pawliuk, R., Westerman, K.A., Fabry, M.E., Payen, E., Tighe, R., Bouhassira, E.E., Acharya, S.A., Ellis, J., London, I.M., Eaves, C.J., Humphries, R.K., Beuzard, Y., Nagel, R.L., and Leboulch, P. (2001). Correction of sickle cell disease in transgenic mouse models of gene therapy. Science 294, 2368-2371.
42. Picardi, M., De Rosa, G., Selleri, C., Scarpato, N., Soscia, E., Martinelli, V., Ciancia, R., and Rotoli, B. (2003). Splenic enlargement following rh-G-CSF administration for peripheral blood stem cell mobilization. Hematologica 88, 794-800.
43. Platzbecker, U., Prange-Krex, G., Bornhäuser, M., Koch, R., Soucek, S., Aikele, P., Haack, A., Haag, C., Schuler, U., Berndt, A., Rutt, C., Ehninger, G., and Hölig, K. (2001) Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 41, 184-189.
44. Puthenveetil, G., Scholes, J., Carbonell, D., Qureshi, N., Xia, P., Zeng, L., Li, S., Yu, Y., Hiti, A.L., Yee, J.K., and Malik, P. (2004). Successful correction of the human b-thalassemia major phenotype using a lentiviral vector. Blood 104, 3445-3453.
45. Ramirez, P., Rettig, M.P., Uy, G.L., Deych, E., Holt, M.S., Ritchey, J.K., and DiPersio, J.F. (2009). BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood 114, 1340-1343.
46. Rivella, S., May, C., Chadburn, A., Riviere, I., and Sadelain, M. (2003). A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human b-globin gene transfer. Blood 101, 2932-2939.
47. Roberts, A., Hasegawa, M., Metcalf, D., and Foote, S.J. (2000). Identification of a genetic locus modulating splenomegaly induced by granulocyte colony-stimulating factor in mice. Leukemia 14, 657-661.
48. Stoyanova, E., Trudel, M., Felfty, H., Garcia, D., and Gloutier, G. (2007). Characterization of circulatory disorders in b-thalassemic mice by noninvasive ultrasound biomicroscopy. Physiol. Genomics 29, 84-90.
49. Stroncek, D., Shawker, T., Follmann, D., and Leiman, S.F. (2003). G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 43, 609-613.
50. Thomasson, B., Peterson, L., Thompson, J., Goerner, M., and Kiem H.-P. (2003). Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for trans-duction of hematopoietic stem cells in dogs. Hum. Gene Ther. 14, 1683-1686.
51. To, L.B., Haylock, D.N., Simmons, P.J., and Juttner, C.A. (1997). The biology and clinical uses of blood stem cells. Blood 89, 2233-2258.
52. Trudel, M., De Paepe, M.E., Chrétien, N., Saadane, N., Jacmain, J., Sorette, M., Hoang, T., and Beuzard, Y. (1994). Sickle cell disease of transgenic SAD mice. Blood 84, 3189-3197.
53. Vlachaki, E., Ioannidou-Papagiannaki, E., Tziomalos, K., Har-alambidou-Vranitsa, S., Perifanis, V., Klonizakis, I., and Athanassiou-Metaxa, M. (2007). Peripheral blood haematopoietic progenitor cells in patients with b thalassaemia major receiving desferrioxamine or deferiprone as chelation therapy. Eur. J. Hematol. 78, 48-51.
54. Welte, K., Platzer, E., Lu, L., Gabrilove, J.L., Levi, E., Mertelsmann, R., and Moore, M.A. (1985). Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 5, 1526-1530.
55. Yang, B., Kirby, S., Lewis, J., Detloff, P.J., Maedam, N., and Smithies, O. (1995). A mouse model for b-thalassemia. Proc. Natl. Acad. Sci. U.S.A. 92, 11608-11612.
56. Yannaki, E., Anagnostopoulos, A., Kapetanos, D., Xagorari, A., Iordanidis, F., Batsis, I., Kaloyannidis, P., Athanasiou, E., Dourvas, G., Kitis, G., and Fassas, A. (2006). Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp. Hematol. 34, 1583-1587.